Theravance Biopharma, Inc. - Ordinary Shares (TBPH)

15.14
-0.05 (-0.33%)
NASDAQ · Last Trade: Mar 27th, 1:46 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy
Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced the launch of “Power in the Periphery,” a new disease education campaign for healthcare professionals (HCPs) to raise awareness and deepen scientific understanding of the pathophysiology underlying neurogenic orthostatic hypotension (nOH) associated with Multiple System Atrophy (MSA). The initiative was introduced at the International Congress of Parkinson’s Disease and Movement Disorders® (MDS), held in Honolulu, Hawaii, October 5–9, 2025.
By Theravance Biopharma · Via Business Wire · October 16, 2025
Sidoti Events, LLC's Virtual June Small-Cap Conference
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Via ACCESSWIRE · June 11, 2024
Irenic Sends Letter to Theravance Biopharma Regarding the Urgent Need for a Governance Overhaul, Capital Return and Strategic Review
Irenic Capital Management, LP, a top shareholder of Theravance Biopharma, Inc. (NASDAQ: TBPH), today released the below letter.
By Irenic Capital Management, LP · Via Business Wire · February 27, 2023